158 results on '"Zima E"'
Search Results
2. On the Structure of Solutions to the Key Gosper Equation in Problems of Symbolic Summation
- Author
-
Zima, E. V.
- Published
- 2023
- Full Text
- View/download PDF
3. Differential effects of inotropes and inodilators on renal function in acute cardiac care
- Author
-
Zima, E. Farmakis, D. Pollesello, P. Parissis, J.T.
- Subjects
urologic and male genital diseases - Abstract
Pathological interplay between the heart and kidneys is widely encountered in heart failure (HF) and is linked to worse prognosis and quality of life. Inotropes, along with diuretics and vasodilators, are a core medical response to HF but decompensated patients who need inotropic support often present with an acute worsening of renal function. The impact of inotropes on renal function is thus potentially an important influence on the choice of therapy. There is currently relatively little objective data available to guide the selection of inotrope therapy but recent direct observations on the effects of levosimendan and milrinone on glomerular filtration favour levosimendan. Other lines of evidence indicate that in acute decompensated HF levosimendan has an immediate renoprotective effect by increasing renal blood flow through preferential vasodilation of the renal afferent arterioles and increases in glomerular filtration rate: potential for renal medullary ischaemia is avoided by an offsetting increase in renal oxygen delivery. These indications of a putative renoprotective action of levosimendan support the view that this calcium-sensitizing inodilator may be preferable to dobutamine or other adrenergic inotropes in some settings by virtue of its renal effects. Additional large studies will be required, however, to clarify the renal effects of levosimendan in this and other relevant clinical situations, such as cardiac surgery. © 2020 Oxford University Press. All rights reserved.
- Published
- 2021
4. Interaction of Ca-sensitiser levosimendan and different catecholamines in chronic heart failure: Experimental studies: P4.9
- Author
-
Sax, B., Nagy, K. V., Végh, E. M., Kosztin, A., Szucs, G., Zima, E., Turi-Kovacs, N., Kekesi, V., and Merkely, B.
- Published
- 2014
5. Poly (ADP-ribose) polymerase (PARP) activation in chronic heart failure correlates with the level of cardiac dysfunction: P4.1
- Author
-
Simon, A., Benkő, R., Szabó, G., Oláh, A., Nagy, K. V., Mátyás, Cs., Hajas, Á., Kosztin, A., Pólos, M., Hartyánszky, I., Zima, E., Radovits, T., Merkely, B., and Horváth, E. M.
- Published
- 2014
6. Complement Activation and its Prognostic role in Post-cardiac Arrest Patients
- Author
-
Jenei, Z. M., Zima, E., Csuka, D., Munthe-Fog, L., Hein, E., Széplaki, G., Becker, D., Karádi, I., Prohászka, Z., Garred, P., and Merkely, B.
- Published
- 2014
- Full Text
- View/download PDF
7. Cunningham numbers in modular arithmetic
- Author
-
Zima, E. V. and Stewart, A. M.
- Published
- 2007
- Full Text
- View/download PDF
8. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
- Author
-
Farmakis, D. Agostoni, P. Baholli, L. Bautin, A. Comin-Colet, J. Crespo-Leiro, M.G. Fedele, F. García-Pinilla, J.M. Giannakoulas, G. Grigioni, F. Gruchała, M. Gustafsson, F. Harjola, V.-P. Hasin, T. Herpain, A. Iliodromitis, E.K. Karason, K. Kivikko, M. Liaudet, L. Ljubas-Maček, J. Marini, M. Masip, J. Mebazaa, A. Nikolaou, M. Ostadal, P. Põder, P. Pollesello, P. Polyzogopoulou, E. Pölzl, G. Tschope, C. Varpula, M. von Lewinski, D. Vrtovec, B. Yilmaz, M.B. Zima, E. Parissis, J.
- Abstract
Inotropes aim at increasing cardiac output by enhancing cardiac contractility. They constitute the third pharmacological pillar in the treatment of patients with decompensated heart failure, the other two being diuretics and vasodilators. Three classes of parenterally administered inotropes are currently indicated for decompensated heart failure, (i) the beta adrenergic agonists, including dopamine and dobutamine and also the catecholamines epinephrine and norepinephrine, (ii) the phosphodiesterase III inhibitor milrinone and (iii) the calcium sensitizer levosimendan. These three families of drugs share some pharmacologic traits, but differ profoundly in many of their pleiotropic effects. Identifying the patients in need of inotropic support and selecting the proper inotrope in each case remain challenging. The present consensus, derived by a panel meeting of experts from 21 countries, aims at addressing this very issue in the setting of both acute and advanced heart failure. © 2019 The Authors
- Published
- 2019
9. Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry
- Author
-
Komajda, M. Schöpe, J. Wagenpfeil, S. Tavazzi, L. Böhm, M. Ponikowski, P. Anker, S.D. Filippatos, G.S. Cowie, M.R. Aleksanyan, A. Atayan, L. Avetisyan, A. Davtyan, N. Drambyan, M. Gevorgyan, K. Grigoryan, M. Hakobyan, Z. Hayrapetyan, H. Kocharyan, L. Kramarevskaya, T. Melqonyan, A. Muradyan, F. Nanyan, R. Ordyan, A. Ordyan, M. Piruzyan, A. Podosyan, G. Safaryan, K. Sargsyan, T. Sarkisyan, A. Sisakyan, H. Ter-Grigoryan, V. Ustyan, T. Alexopoulos, C. Amerena, J. Arstall, M. Ayres, B. Barron, G. Beltrame, J. Bou-Samra, J. Brown, M. Cross, D. Dwyer, N. Eccleston, N. Hare, D. Ho, B. Hopper, I. Jackson, B. Korczyk, D. Lattimore, J.D. Levendel, A. Macfadyen, R. Pandeli, V. Playford, D. Richardson, M. Senior, J.A. Shah, A. Shetty, P. Soward, A. Srivastava, P. Swale, M. Vogl, E. Wai, B. William, M. Worthington, A. Wright, S. Brunner, B. Fuhrmann, W. Horer, L. Maca, T. Nahler, A. Ortner, H. Racz, G. Scheibner, P. Sebald, C. Abdullayev, A. Abdullayev, R. Ahmadov, A. Alakbarov, E. Aliyev, F. Aliyev, F. Bakhshaliyev, A. Bakhshiyev, M. Dadashova, G. Dashdamirov, R. Faradjova, N. Guliyev, A. Guliyev, F. Guliyeva, S. Hajiyev, G. Ibrahimov, F. Imanov, G. Isayeva, A. Isayeva, M. Jabrailova, U. Jafarov, R. Jahangirov, T. Khalilov, A. Khalilov, S. Mehdiyev, S. Najafov, R. Samedova, H. Shahhuseynov, S. Yusifly, R. Yusifov, T. Zahidova, K. Zeynalov, A. Abdullatif, A. Al-Banna, R. Haiky, W. Husain, A. Jamsheer, A. Barbuk, O. Belskaya, M. Borodko, V. Kurlianskaya, A. Mackevich, S. Mankevich, N. Moroz-Vodolazhskaya, N. Ravtovich, O. Saevich, A. Troyanova, T. Chughtai, A. Johar, S. Luqman, N. Nair, T.C.-R. Deyoung, P. Ezekowitz, J. Frenette, M. Howlett, J. Huynh, T. Nguyen, V. Toma, M. Orenstein, T. Rinne, M.R.C. Virani, S. Zieroth, S. Ailiman, M. Cong, H. Ding, W. Dong, W. Dong, Y. Gao, C. Li, L. Li, Z. Liang, Y. Liu, X. Liu, S. Luo, S. Shi, H. Tian, Q. Wang, D. Wang, J. Wei, M. Wu, C. Xu, D. Yang, X. Yang, Z. Zhang, C. Zhang, Q. Zhang, Y. Zhang, R. Zheng, Y. Zhao, L. Zhou, J. Buch, P. Davidsen, F. Eiskjær, H. Bruun, N.E. Kragh-Thomsen, N.E. Franow, H. Køber, L. Korup, E. Madsen, B.K. Mikkelsen, K. Nielsen, K.A. Nørgaard, A. Refsgaard, J. Rickers, H. Kaiser, P. Sykulski, R. Zeuthen, E.L. El Fottoh, A.A. El Badry, M. El Hady, Y.A. El Kady, E. El Khatib, H. Fawzy, M. Hegazy, H. Salama, M.K. Mortada, A. Mostafa, T. Mwafy, A. Ossama, M. Samir, S. Seleem, M. Sobhy, B. Bregadze, G. Chelidze, K. Chumburidze, V. Jalabadze, K. Khabeishvili, G. Kiphiani, Z. Klimiashvili, Z. Kvitsiani, A. Mamatsashvili, M. Melia, I.M.A. Oragvelidze, T. Orjonikidze, S. Paposhvili, K. Petriashvili, S. Phaghava, Z. Shushania, M. Tsetskhladze, E. Tsinamdzgvishvili, B. Abdel-Qader, M. Al-Zoebi, A. Böhm, G. Bosch, R. Brune, S. Bunge, K. Dominick, K. Duda, S. Erdogan, A.E. Faber, G. Fach, C. Fechtrup, C. Frickel, S. Giokoglu, K. Haas, J. Hagenow, A. Haj-Yehia, A. Hansen, C. Hartung, W.M. Hauser, E.R. Hofmeister, A. Hohensee, H. Hüttemann, M. Keim, M. Krämer, A. Langwasser, K. Lodde, B.P. Lorch, G. Lüer, C. Müller, K. Placke, J. Plesch, B. Potolidis, L. Richter, F. Rieker, W.A. Schlichting, J. Stenzel, G. Theuer, J.D. Marcin, A. Warkentin, R. Wegner, M. Wilke, A. Agrafiotis, I. Aleksandridis, I. Farmakis, D. Giannakoulas, G. Karavidas, A. Lamprou, A. Ninios, V. Panagiotopoulos, K. Papadopoulos, K. Siachos, S. Dékány, M. Borbéy, A. Borsányi, T. Forster, T. Gavallér, H. Gyuricza, I. Heltai, K. Herczeg, B. HŐgye, M. Losonczi, I. Merkely, B. Metz, E. Muk, B. Nagy, K. Ökrös, M. Piry, K. Poós, G. Sárszegi, Z. Somogyi, T. Sziliczei-Németh, E. Tátrai, T. Zima, E. Zsigmond, A. Daly, C. Mahon, N. Meany, B. Abbdi, I. Awaysheh, R. Azouka, M. Hamoudeh, S. Nammas, A. Okkeh, O. Aimakova, G. Ismagulova, Z. Issabekova, A. Junusbekova, G.A. Koshumbayeva, K. Madaliyev, K. Mekebekova, D. Mukatova, A. Ospanova, G. Sadvakassova, G. Sunkarbekova, Z. Yegorova, Y. Zhangelova, S. Kim, K.H. Al-Mutairi, M. Gaber, Y. Ghali, I. Ghanem, A. Hafez, H. Haiba, M. Koushy, T. Mahmoud, A. Raafat, G. Sallam, M. Senousi, O. Soliman, M. Massih, T.A. Ali, S.A. Jaoude, S.A. Azzi, N. Badaoui, G. Bayeh, H. Beydoun, A. Chammas, E. Dib, H. Gebran, M. Ghanem, G. Haidar, H. Hamadeh, M. Hamoui, O. Hobeika, R. Jazra, C. Kabbani, S. Kadri, Z. Karanaminassian, R. Kassab, R. Kleit, M. Mansour, H. Mousallem, N. Semaan, C. Simonian, A. Sarkis, A. Succar, S. Zalloum, R. Zind, R. Anusauskiene, J. Grigaliuniene, A. Karaliute, R. Kavoliuniene, A. Kozlovaite, V. Miliuniene, D. Rinkuniene, D. Rudys, A. Stasaityte, D. Aziz, F.A.A. Rahim, A.A.A. Ahmad, R. Ahmadsah, S.H.K.A. Ang, C.C. Ang, S.H. Cham, Y.L. Chee, K.H. Chooi, K.C. Chu, C.M. Fam, T.L. Fong, A. Ismail, O. Ismail, J.R. Kamarulzaman, M.H. Kasim, S.S. Khiew, N.Z. Krishnan, C. Krishinan, S. Lau, G. Lee, L.Y. Liew, H.B. Lim, C.W. Mahendran, K. Dass, R.D.M. Mohamad, R. Arshad, M.K.M. Unit, H.M. Mustapha, Z. Ng, W.K. Ong, T.K. Oon, Y.Y. Ramli, A.W. Ramanathan, G.R.L. Ross, N.T. Said, A. Sarwar, M. Tan, E. Tan, S.K. Voon, C.Y. Yusoff, M.R. Abidin, H.A.Z. Chua, S.K. Yew, K.L. Amin, N.H.M. Kandiah, K. Chong, L.A. Mohamed, M.S. Lim, B.K. Koh, K.T. Low, D.W. Abdelkhirane, C. Allali, Y. Askour, M. Balafrej, K. Bendagha, N. Bendriss, L. Benjelloun, H. Chaib, A. Cherradi, G. Cherti, M. Chtioui, M. El Belghiti, A.R. Fihri, O.F. Habbal, R. El Hattaoui, M. Khatouri, A. Kheyi, J. Kriem, J. Soufiane, N. Soufiani, A. Zaimi, S. Adamczyk-Kot, D. Barg, Z. Bartkowiak, R. Braciszewicz, W. Czajkowska, E. Dudek-Niechciał, M. Grzelakowski, P. Jarosik, Z. Jerzykowska, O. Koprowski, P. Krysiak, W. Łajkowski, Z. Ziemlewska-Krawczyk, E. Lelonek, M. Lewicka, E. Płonka, J. Sadowski, J. StĘpieŃ-Adamczewska, V. Szponar, J. WrzesiŃski, K. Brito, D.A. Araújo, I. Figueiredo, J.P.A. Campelo, M.B. Sardinha, P.M.B. Fernando, P. de Brito Domingues Sanches Peres de Noronha, M.A. Baptista, S.B.C. Cardoso Pinto, J.P. Piçarra, B.M.C. Farto e Abreu, P. da Fonseca, M.C.F.G. Soares, A.I.C.G.O. Resende, J.D.A. Durão, D.L. Nascimento, A.I.F.V. Bernardes, E.L.M.O. Marques, F. Ramos, M.A.N. Sargento, L.J.M. dos Santos, J.P.F. Raimundo, A. da Luz Ventosa, A.M.S. Sarmento, P. Aguiar, C.M.T. Ahmed, E. Al-Suwaidi, J. Al Dabdoob, W. Badr, A. Gomaa, M. Albu, M. Antohi, I. Apavaloaei, C. Ardelean, A. Badea, G. Bicescu, G. Blaj, C. Bogdan, L. Bucatanschi, M. Buzea, A. Calarasu, V. Catinean, S. Christodorescu, R. Cocoi, D. Costache, L. Cretu, D. Crisu, D. Dima-Cozma, C. Dumitrescu, S. Enache, V. Firastrau, V. Frigy, A. Gherghina, A. Girbea, S. Gutu, A. Horovitz, M. Hortopan, G. Istratoaie, O. Jianu, C. Jinga, L. Lighezan, D. Luka, A. Magheru, S. Mercea, D. Miklos, K. Moga, R. Oprea, N. Paraschiv, D.M. Pop, D. Rusu, R. Sirbu, I. Socoteanu, E. Stanciulescu, G. Suteu, A. Tetiu, O. Traistaru, A. Tudoran, M. Turiceanu, M.C. Viinkler, L. Adonina, E. Akinina, S. Alferov, P. Arkhipov, M. Aroutunov, G. Babkin, A. Barbashina, T. Bochkareva, J. Boldueva, S. Bukhonkina, J. Chumakova, S.G. Fayans, I. Furmenko, G. Galyavich, A. Grinstein, Y. Klein, G. Kastanayan, A. Kazachkova, T. Korolev, S. Koshelskaya, O. Kosmacheva, E. Koziolova, N. Kuimov, A. Kushnarenko, N. Lebedev, P. Matushin, G. Mineeva, E. Motylev, I. Nedbaykin, A. Nevzorova, V. Rachkova, S. Rebrov, A. Reznik, I. Saiganov, S. Sayfutdinov, R. Schekotov, V. Serdechnaya, E. Shalaev, S. Shtegman, O. Sitnikova, M. Smolenskaya, O. Sulimov, V. Tarlovskaya, E. Temnikova, E. Timonin, D. Tolstov, S. Uskatch, T. Ustyuzhanin, V. Valeeva, R. Vasyuk, Y. Viktorova, I. Yakushin, S. Zadionchenko, V. Zateischikov, D. Zhirov, I. Bollová, D. Dulková, K. Fazekaš, F. Hermel, I. KŇazeje, M. NedĚĽová, I. Nociar, J. Procházka, L. Pundová, L. Slanina, M. Varga, I. Almenar, L. Beltrán, P. Cobo, M. Delgado, J. Enjuanes, C. Garrido, I. Gómez, M.A. Manito, N. Marzal, D. Murga, N. Ocampo, M. Pérez, J. Sánchez, I. Buakhamsri, A. Leemasawat, K. Kanoksilp, A. Kiatchoosakun, S. Phrommintikul, A. Porapakkham, P. Rodprasert, S. Senthong, V. Wongcharoen, W. Wongwantanee, S. Bahadir, H. Emül, A. Gokce, M. Gurcagan, A. Kaya, O.K. Keser, A. Pinar, P. Taș, M.H. Tosun, H.B. Yazlar, A.S. Yilmaz, S. Yuksel, Y. Bagriy, A. Ivchyna, N. Lyashenko, A. Matviychuk, N. Shchukina, O. Tkach, N. Tseluyko, V. Vasylieva, L. Abdallah, A. Agrawal, A. Basleeb, F. Bazargani, N. Hatou, E. Al Kaddour, A.R. Al Kasser, M. Al Mulla, A. Radaideh, G. Salustri, A. on behalf of the QUALIFY Investigators
- Abstract
Background: Physicians' adherence to guideline-recommended therapy is associated with short-term clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF). However, its impact on longer-term outcomes is poorly documented. Here, we present results from the 18-month follow-up of the QUALIFY registry. Methods and results: Data at 18 months were available for 6118 ambulatory HFrEF patients from this international prospective observational survey. Adherence was measured as a continuous variable, ranging from 0 to 1, and was assessed for five classes of recommended HF medications and dosages. Most deaths were cardiovascular (CV) (228/394) and HF-related (191/394) and the same was true for unplanned hospitalizations (1175 CV and 861 HF-related hospitalizations, out of a total of 1541). According to univariable analysis, CV and HF deaths were significantly associated with physician adherence to guidelines. In multivariable analysis, HF death was associated with adherence level [subdistribution hazard ratio (SHR) 0.93, 95% confidence interval (CI) 0.87–0.99 per 0.1 unit adherence level increase; P = 0.034] as was composite of HF hospitalization or CV death (SHR 0.97, 95% CI 0.94–0.99 per 0.1 unit adherence level increase; P = 0.043), whereas unplanned all-cause, CV or HF hospitalizations were not (all-cause: SHR 0.99, 95% CI 0.9–1.02; CV: SHR 0.98, 95% CI 0.96–1.01; and HF: SHR 0.99, 95% CI 0.96–1.02 per 0.1 unit change in adherence score; P = 0.52, P = 0.2, and P = 0.4, respectively). Conclusion: These results suggest that physicians' adherence to guideline-recommended HF therapies is associated with improved outcomes in HFrEF. Practical strategies should be established to improve physicians' adherence to guidelines. © 2019 The Authors. European Journal of Heart Failure © 2019 European Society of Cardiology
- Published
- 2019
10. Invasive management of iatrogenic pulmonary vein stenosis is effective in patients after atrial fibrillation ablation
- Author
-
Maurovich Horvath, P, Bartykovski, A, Jermendy, A, Ostheimer, I, Merkely, B, ÖZCAN, EMİN EVREN, Szegedi, Nandor, TAHIN, T, Nagy, KV, Zima, E, Szeplaki, Gabor, Geller, Laszlo, Bettenbuch, T, Srej, M, and Szabo, T
- Published
- 2016
11. Transseptal endocardial left ventricular lead implantation after failed CRT implantation-long term results
- Author
-
Szilagyi, S. Z., Geller, L. A., Molnar, L., Zima, E., Szeplaki, G., Nagy, V. K., Apor, A., Sallo, Z., Merkely, B., and ÖZCAN, EMİN EVREN
- Published
- 2015
12. Larger interventricular lead distance at implantation is associated with improvement in biomarkers, ejection fraction and clinical outcome in crt patients
- Author
-
Kutyifa, V., Zima, E., Szilagyi, S. Z., Merkely, B., Molnar, L., ÖZCAN, EMİN EVREN, Geller, L., Nagy, V. K., Kosztin, A., and Szeplaki, G.
- Published
- 2014
13. Long term efficacy and safety of transseptal endocardial left ventricular lead implantation after left ventricular lead implantations
- Author
-
Szilagyi, S. Z., ÖZCAN, EMİN EVREN, Merkely, B., Molnar, L., Apor, A., Osztheimer, I., Szeplaki, G., Zima, E., Tahin, T., and Geller, L.
- Published
- 2014
14. PM136 The Effect of the Primary Care System on the Long Term Prognosis of Patients With St Segment Elevation Myocardial Infarction
- Author
-
Becker, D., Kosztin, A., Barczi, G., Heltai, K., Zima, E., Vago, H., and Merkely, B.
- Published
- 2016
- Full Text
- View/download PDF
15. Shiftless decomposition and polynomial-time rational summation.
- Author
-
Gerhard, J., Giesbrecht, M., Storjohann, A., and Zima, E. V.
- Published
- 2003
- Full Text
- View/download PDF
16. How fast can we compute products?
- Author
-
Kislenkov, V., Mitrofanov, V., and Zima, E.
- Published
- 1999
- Full Text
- View/download PDF
17. Usefulness of electroanatomical mapping during transseptal endocardial left ventricular lead implantation.
- Author
-
Kutyifa V, Merkely B, Szilágyi S, Zima E, Róka A, Király A, Osztheimer I, Molnár L, Széplaki G, and Gellér L
- Published
- 2012
18. Multidimensional chains of recurrences.
- Author
-
Kislenkov, V., Mitrofanov, V., and Zima, E.
- Published
- 1998
- Full Text
- View/download PDF
19. Numeric code optimization in computer algebra systems and recurrent relations technique.
- Author
-
Zima, E. V.
- Published
- 1993
- Full Text
- View/download PDF
20. A New Detection Algorithm for Implantable Cardioverter Defibrillator.
- Author
-
Merkely, B., Zima, E., Geller, L., Lang, V., and Schaldach, M.
- Published
- 2001
- Full Text
- View/download PDF
21. Convergence of employers’ and students’ expectations in the educational environment of the agricultural university
- Author
-
Razinkina Elena, Zima Elena, Pozdeeva Elena, Evseeva Lidiya, and Tanova Anna
- Subjects
Environmental sciences ,GE1-350 - Abstract
In the digital age, a modern university is becoming a driver for the development of complex multi-agent ecosystems and a supplier of a new type of human resources, characterized not only by intellectual potential and high qualifications but also by such qualities in demand in the labor market as creativity, critical thinking, the need for continuous learning and “agency”, which is understood as the ability to self-organize and proactivity [1]. The education system and universities themselves face challenges that force us to turn to the once-actual ideas of integration and convergence, which can fulfill the increased need to achieve synergy effects and multiplier indicators that contribute to achieving high ratings in a short time. It is convergent processes that lie at the heart of the developing communicative space of the university today, whose activities are based on the intersection of the interests and expectations of various actors, which are implemented on multi-agent platforms. At the same time, the opportunities that are opening up due to the rapid introduction of digital technologies require restructuring the space of interactions between subjects towards the formation of flexible forms, network models, alliances, virtual corporations, connecting clusters built on the principles of active cooperation, exchange of best practices and developments.
- Published
- 2021
- Full Text
- View/download PDF
22. Formation of digital competencies in higher education as the basis for realization of sustainable development goals
- Author
-
Razinkina Elena, Zima Elena, and Pankova Lyudmila
- Subjects
Environmental sciences ,GE1-350 - Abstract
The formation of digital competencies of citizens is currently a strategic goal for the Russian education system from the perspective of realization of sustainable development goals. The article considers the level model of digital competencies within higher education programmes at the SPbPU, the key feature of which is a universal core that allows to facilitate sequential growth of competencies and implement flexible educational trajectories of students within the “2+2+2” model.
- Published
- 2021
- Full Text
- View/download PDF
23. The system of professional development and assessment of the competencies of university teaching staff to ensure quality education in the interests of sustainable development of society: a case study of Russia
- Author
-
Razinkina Elena, Kalinina Olga, and Zima Elena
- Subjects
Environmental sciences ,GE1-350 - Abstract
This article substantiates the need to form a comprehensive system of professional development and assessment of teachers’ competencies in order to ensure quality education in the interests of sustainable development of society. The main goals and objectives are formulated and the methodological tools developed by the authors for the formation of this system are described. The features of the implementation of the system in the practice of conducting the educational process at Peter the Great St. Petersburg Polytechnic University (St. Petersburg, Russia) are revealed. The risks are identified and recommendations for their minimization are given for other educational organizations of higher education that implement a comprehensive system of professional development and assessment of the competencies of teachers using digital services.
- Published
- 2021
- Full Text
- View/download PDF
24. Comparison of efficacy of two cooling methods: Blanketrol versus conventional physical cooling
- Author
-
Kovács, E., Jenei, Z.S., Osztheimer, I., Szilágyi, S.Z., Molnár, L., Gellér, L., Merkely, B., and Zima, E.
- Published
- 2010
- Full Text
- View/download PDF
25. Retrospective analysis of survival data of in-hospital and out-of-hospital resuscitated patients in the practice of Semmelweis University Heart Centre
- Author
-
Zima, E., Jenei, Z., Kovacs, E., Barany, T., Osztheimer, I., Nardai, S., Geller, L., and Merkely, B.
- Published
- 2010
- Full Text
- View/download PDF
26. Sudden Cardiac Death and Post Cardiac Arrest Syndrome. An Overview
- Author
-
Zima Endre
- Subjects
cardiac arrest ,therapeutic hypothermia ,cardiopulmonary resuscitation ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
A satisfactory neurologic outcome is the key factor for survival in patients with sudden cardiac death (SCD), however this is highly dependent on the haemodynamic status. Short term cardiopulmonary resuscitation and regained consciousness on the return of spontaneous circulation (ROSC) is indicative of a better prognosis. The evaluation and treatment of SCD triggering factors and of underlying acute and chronic diseases will facilitate prevention and lower the risk of cardiac arrest. Long term CPR and a prolonged unconscious status after ROSC, in the Intensive Care Units or Coronary Care Units, indicates the need for specific treatment and supportive therapy including efforts to prevent hyperthermia. The prognosis of these patients is unpredictable within the first seventy two hours, due to unknown responses to therapeutic management and the lack of specific prognostic factors. Patients in these circumstances require the highest level of intensive care and aetiology driven treatment without any delay, independently of their coma state. Current guidelines sugest the use of multiple procedures in arriving at a diagnosis and prognosis of these critical cases.
- Published
- 2015
- Full Text
- View/download PDF
27. PMD62 - Cost-Effectiveness Analysis Of Continuous Remote Monitoring Of Heart Failure Patients With Cardiac Electronic Implantable Device
- Author
-
Malbaski, N, Balazs, T, Dozsa, C, and Zima, E
- Published
- 2015
- Full Text
- View/download PDF
28. Gold-tip electrodes-a new 'deep lesion' technology for catheter ablation? in vitro comparison of a gold alloy versus platinum-iridium tip electrode ablation catheter.
- Author
-
Lewalter T, Bitzen A, Wurtz S, Blum R, Schlodder K, Yang A, Lickfett L, Schwab JO, Schrickel JW, Tiemann K, Linhart M, Zima E, Merkely B, and Lüderitz B
- Abstract
Gold-Tip Electrodes . Radiofrequency (RF) catheter ablation is widely used to induce focal myocardial necrosis using the effect of resistive heating through high-frequency current delivery. It is current standard to limit the target tissue-electrode interface temperature to a maximum of 60-70°C to avoid char formation. Gold (Au) exhibits a thermal conductivity of nearly four times greater than platinum (Pt-Ir) (3.17 W/cm Kelvin vs 0.716 W/cm Kelvin), it was therefore hypothesized that RF ablation using a gold electrode would create broader and deeper lesions as a result of a better heat conduction from the tissue-electrode interface and additional cooling of the gold electrode by 'heat loss' to the intracardiac blood. Both mechanisms would allow applying more RF power to the tissue before the electrode-tissue interface temperature limit is reached. To test this hypothesis, we performed in vitro isolated liver and pig heart investigations comparing lesion depths of a new Au-alloy-tip electrode to standard Pt-Ir electrode material. Mean lesion depth in liver tissue for Pt-Ir was 4.33 ± 0.45 mm (n = 60) whereas Au electrode was able to achieve significantly deeper lesions (5.86 ± 0.37 mm [n = 60; P < 0.001]). The mean power delivered using Pt-Ir was 6.95 ± 2.41 W whereas Au tip electrode delivered 9.64 ± 3.78 W indicating a statistically significant difference (P < 0.05). In vitro pig heart tissue Au ablation (n = 20) increased significantly the lesion depth (Au: 4.85 ± 1.01 mm, Pt-Ir: 2.96 ± 0.81 mm, n = 20; P < 0.001). Au tip electrode again applied significantly more power (P < 0.001). Gold-tip electrode catheters were able to induce deeper lesions using RF ablation in vitro as compared to Pt-Ir tip electrode material. In liver and in pig heart tissue, the increase in lesion depth was associated with a significant increase in the average power applied with the gold electrode at the same level of electrode-tissue temperature as compared to platinum material. (J Cardiovasc Electrophysiol, Vol. 16, pp. 1-3, June 2005) [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
29. PMD62 Cost-Effectiveness Analysis Of Continuous Remote Monitoring Of Heart Failure Patients With Cardiac Electronic Implantable Device
- Author
-
Malbaski, N, Balazs, T, Dozsa, C, and Zima, E
- Subjects
health care economics and organizations - Full Text
- View/download PDF
30. Successful management and long term outcome of an accidental subclavian artery injury with a 9 french dilator during pacemaker implantation with collagen-based closure device.
- Author
-
Molnár L, Szucs G, Zima E, Szilágyi S, Kutyifa V, Becker D, Gellér L, Merkely B, Molnár, Levente, Szucs, Gábor, Zima, Endre, Szilágyi, Szabolcs, Kutyifa, Valentina, Becker, Dávid, Gellér, László, and Merkely, Béla
- Abstract
Subclavian artery puncture and dilation with 9 Fr dilator during pacemaker implantation is a rare complication. We present a case, where this complication occurred and the injury was sealed with collagen-based closure device without any complications. Long term follow-up and the control angio-CT revealed no further late vascular complications. Therefore, use of a collagen based closure device for treating accidental iatrogenic subclavian artery injury can be a simple, successful alternative therapy when surgical direct vascular repair is not possible or not available. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
31. INTRACARDIAC IMPEDANCE AS HEMODYNAMIC SENSOR: FEASIBILITY STUDY.
- Author
-
Lippert, M., Zima, E., Czygan, G., and Merkely, B.
- Published
- 2003
- Full Text
- View/download PDF
32. Standalone MCR-based numerical engine.
- Author
-
Mitrofanov, V. A. and Zima, E. V.
- Published
- 1997
- Full Text
- View/download PDF
33. Heart rate variability changes preceding spontaneous ventricular tachyarrhythmias in ICD patients.
- Author
-
Zima, E., Szücs, A., Gellér, L., Kiss, O., Vágó, H., Bielik, H., and Merkely, B.
- Published
- 2000
34. Clinical results with the dual chamber cardioverter defibrillator phylax av and tachos dr-msv. efficacy of smart 1 and 2 discrimination algorhythm.
- Author
-
Merkely, B., Bielik, H., Zima, E., Vágó, H., and Gellér, L.
- Published
- 2000
35. Comparing the arrhythmogenic effect of endothelin-1 using intracoronary bolus administration and continuous infusion.
- Author
-
Vágó, H, Kiss, O, Zima, E, Szabó, T, Szücs, A, Juliász-Nagy, A, Gellér, L, and Merkely, B
- Published
- 2000
36. CMO's role expands: chief medical officers take on technology, revenue responsibilities.
- Author
-
Zima E
- Published
- 2003
37. Vitamin D Deficiency Predicts Poor Clinical Outcomes in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy.
- Author
-
Perge, P., Boros, A. M., Gellér, L., Osztheimer, I., Szilágyi, Sz, Tahin, T., Apor, A., Nagy, K. V., Zima, E., Molnár, L., Merkely, B., and Széplaki, G.
- Subjects
- *
CARDIAC pacing , *VITAMIN D deficiency , *HEART failure patients , *HEART disease related mortality , *CARDIAC patients , *VITAMIN D - Abstract
Background and Aims. Resynchronization therapy (CRT) improves mortality and induces reverse remodeling in heart failure (HF) patients with reduced ejection fraction and wide QRS. Nonetheless, some patients do not improve despite the optimal medical therapy and right indications for device implantation. Therefore, finding biomarkers suitable for identification of those patients is crucial. Vitamin D plays a classic hormonal role in the regulation of bone metabolism and also has physiological functions in wide range of nonskeletal tissues. Based on recent studies, low levels of vitamin D seem to directly contribute to pathogenesis and worsening of HF. We planned to assess the role of vitamin D levels on clinical outcomes of HF patients undergoing CRT. Methods and Results. We enrolled 136 HF patients undergoing CRT. Total plasma vitamin D levels were measured at baseline and 6 months later. Primary endpoint was 5-year all-cause mortality; secondary endpoint was lack of good clinical response, defined as less than 15% increase of left ventricular ejection fraction after six months. During follow-up, 58 patients reached the primary, and 45 patients reached the secondary endpoint. Vitamin D levels less than 24.13 ng/mL predicted 5-year mortality (p=0.045) and poor clinical response (p=0.03) after adjusting to all significant baseline predictors. Conclusion. Our study showed that vitamin D deficiency has a significant impact in heart failure patients; it is an independent predictor of lack of midterm clinical response and long-term mortality in patients undergoing CRT. Therefore, monitoring vitamin D status of heart failure patients could be of clinical significance. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
38. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
- Author
-
Konstantinides, Stavros V., Meyer, Guy, Becattini, Cecilia, Bueno, Hector, Geersing, Geert-Jan, Harjola, Veli-Pekka, Huisman, Menno V., Humbert, Marc, Jennings, Catriona Sian, Jimenez, David, Kucher, Nils, Lang, Irene Marthe, Lankeit, Mareike, Lorusso, Roberto, Mazzolai, Lucia, Meneveau, Nicolas, Ni Ainle, Fionnuala, Prandoni, Paolo, Pruszczyk, Piotr, Righini, Marc, Torbicki, Adam, Van Belle, Eric, Luis Zamorano, Jose, Nazzareno, Galié, J Simon, R Gibbs, Victor, Aboyans, Walter, Ageno, Stefan, Agewall, Ana, G Almeida, Felicita, Andreotti, Emanuele, Barbato, Johann, Bauersachs, Andreas, Baumbach, Farzin, Beygui, Jørn, Carlsen, Marco De Carlo, Marion, Delcroix, Victoria, Delgado, Pilar Escribano Subias, Donna, Fitzsimons, Sean, Gaine, Samuel, Z Goldhaber, Deepa, Gopalan, Gilbert, Habib, Sigrun, Halvorsen, David, Jenkins, Hugo, A Katus, Barbro, Kjellström, Mitja, Lainscak, Patrizio, Lancellotti, Geraldine, Lee, Grégoire Le Gal, Emmanuel, Messas, Joao, Morais, Steffen, E Petersen, Anna Sonia Petronio, Massimo Francesco Piepoli, Susanna, Price, Marco, Roffi, Aldo, Salvi, Olivier, Sanchez, Evgeny, Shlyakhto, Iain, A Simpson, Stefan, Stortecky, Matthias, Thielmann, Anton Vonk Noordegraaf, Cecilia, Becattini, Héctor, Bueno, Geert-Jan, Geersing, Veli-Pekka, Harjola, Menno, V Huisman, Marc, Humbert, Catriona Sian Jennings, David, Jiménez, Nils, Kucher, Irene Marthe Lang, Mareike, Lankeit, Roberto, Lorusso, Lucia, Mazzolai, Nicolas, Meneveau, Fionnuala Ní Áinle, Paolo, Prandoni, Piotr, Pruszczyk, Marc, Righini, Adam, Torbicki, Eric, Vanbelle, José, Luiszamorano, Stephan, Windecker, Colin, Baigent, Jean-Philippe, Collet, Veronica, Dean, Chris, P Gale, Diederick, Grobbee, Gerhard, Hindricks, Bernard, Iung, Peter, Jüni, Ulf, Landmesser, Christophe, Leclercq, Maddalena, Lettino, Basil, S Lewis, Bela, Merkely, Christian, Mueller, Dimitrios, J Richter, Miguel, Sousa-Uva, Rhian, M Touyz, Naima, Hammoudi, Hamlet, Hayrapetyan, Julia, Mascherbauer, Firdovsi, Ibrahimov, Oleg, Polonetsky, Mariya, Tokmakova, Bosko, Skoric, Ioannis, Michaloliakos, Martin, Hutyra, Søren, Mellemkjaer, Mansour, Mostafa, Julia, Reinmets, Pertti, Jääskeläinen, Denis, Angoulvant, George, Giannakoulas, Endre, Zima, Vizza, Carmine Dario, Akhmetzhan, Sugraliyev, Ibadete, Bytyçi, Aija, Maca, Egle, Ereminiene, Steve, Huijnen, Robert, Xuereb, Nadejda, Diaconu, Nebojsa, Bulatovic, Ilyasse, Asfalou, Marijan, Bosevski, Bożena, Sobkowicz, Daniel, Ferreira, Antoniu Octavian Petris, Olga, Moiseeva, Marco, Zavatta, Slobodan, Obradovic, Iveta, Šimkova, Peter, Radsel, Borja, Ibanez, Gerhard, Wikström, Drahomir, Aujesky, Cihangir, Kaymaz, Alexander, Parkhomenko, Joanna, Pepke-Zaba, University of Zurich, Konstantinides, Stavros V, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Konstantinides S.V., Meyer G., Bueno H., Galie N., Gibbs J.S.R., Ageno W., Agewall S., Almeida A.G., Andreotti F., Barbato E., Baumbach A., Beygui F., Carlsen J., De Carlo M., Delcroix M., Subias P.E., Gaine S., Goldhaber S.Z., Gopalan D., Habib G., Jenkins D., Kjellstrom B., Lainscak M., Lee G., Le Gal G., Messas E., Morais J., Piepoli M.F., Price S., Salvi A., Sanchez O., Stortecky S., Thielmann M., Noordegraaf A.V., Becattini C., Geersing G.-J., Harjola V.-P., Huisman M.V., Humbert M., Jennings C.S., Jimenez D., Kucher N., Lang I., Lankeit M., Lorusso R., Mazzolai L., Meneveau N., Ainle F.N., Prandoni P., Pruszczyk P., Righini M., Torbicki A., Van Belle E., Zamorano J.L., Windecker S., Aboyans V., Baigent C., Collet J.-P., Dean V., Delgado V., Fitzsimons D., Gale C.P., Grobbee D.E., Hindricks G., Iung B., Juni P., Katus H.A., Landmesser U., Leclercq C., Lettino M., Lewis B.S., Merkely B., Mueller C., Petersen S.E., Petronio A.S., Richter D.J., Roffi M., Shlyakhto E., Simpson I.A., Sousa-Uva M., Touyz R.M., Hammoudi N., Hayrapetyan H., Mascherbauer J., Ibrahimov F., Polonetsky O., Lancellotti P., Tokmakova M., Skoric B., Michaloliakos I., Hutyra M., Mellemkjaer S., Mansour M., Reinmets J., Jaaskelainen P., Angoulvant D., Bauersachs J., Giannakoulas G., Zima E., Vizza C.D., Sugraliyev A., Bytyci I., Maca A., Ereminiene E., Huijnen S., Xuereb R., Diaconu N., Bulatovic N., Asfalou I., Bosevski M., Halvorsen S., Sobkowicz B., Ferreira D., Petris A.O., Moiseeva O., Zavatta M., Obradovic S., Simkova I., Radsel P., Ibanez B., Wikstrom G., Aujesky D., Kaymaz C., Parkhomenko A., Pepke-Zaba J., CTC, MUMC+: MA Med Staf Spec CTC (9), and RS: Carim - V04 Surgical intervention
- Subjects
ORAL ANTICOAGULANT-THERAPY ,diagnosis ,[SDV]Life Sciences [q-bio] ,Medizin ,030204 cardiovascular system & hematology ,Embolectomy ,Guideline ,RECURRENT VENOUS THROMBOEMBOLISM ,0302 clinical medicine ,Pregnancy ,Daily practice ,Diagnosis ,Pulmonary medicine ,Venous thrombosis ,Pulmonary Medicine ,Thrombolytic Therapy ,DEEP-VEIN THROMBOSIS ,Disease management (health) ,Societies, Medical ,ComputingMilieux_MISCELLANEOUS ,health care economics and organizations ,Risk assessment ,ddc:616 ,RIGHT-VENTRICULAR DYSFUNCTION ,Disease Management ,Shock ,MOLECULAR-WEIGHT HEPARIN ,Thrombolysis ,humanities ,3. Good health ,Pulmonary embolism ,Europe ,Anticoagulation ,Biomarkers ,Dyspnoea ,Echocardiography ,Guidelines ,Heart failure ,Right ventricle ,Treatment ,Venous thromboembolism ,medicine.vein ,Acute Disease ,Medical emergency ,Cardiology and Cardiovascular Medicine ,guidelines ,pulmonary embolism ,venous thrombosis ,shock dyspnoea ,heart failure: right ventricle: diagnosis ,risk assessment: echocardiography ,biomarkers ,treatment ,anticoagulation ,thrombolysis ,pregnancy ,venous thromboembolism ,embolectomy ,Diagnosi ,education ,Cardiology ,MEDLINE ,Thrombolysi ,610 Medicine & health ,Inferior vena cava ,2705 Cardiology and Cardiovascular Medicine ,EXTRACORPOREAL MEMBRANE-OXYGENATION ,03 medical and health sciences ,Medical ,medicine ,Humans ,RIGHT HEART THROMBI ,VENTILATION-PERFUSION SCINTIGRAPHY ,Health professionals ,business.industry ,INFERIOR VENA-CAVA ,10031 Clinic for Angiology ,Anticoagulants ,030229 sport sciences ,Biomarker ,medicine.disease ,INHALED NITRIC-OXIDE ,Societies ,business - Abstract
Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.
- Published
- 2019
- Full Text
- View/download PDF
39. A comparison of three heuristics to choose the variable ordering for CAD
- Author
-
Huang, Zongyan, England, Matthew, Wilson, David, Davenport, James H., Paulson, Lawrence C., Zima, E., Caboara, M., Dumas, J-G., Gonzalez-Vega, L., Wester, M., and Zhi, L.
- Subjects
ComputingMethodologies_SYMBOLICANDALGEBRAICMANIPULATION - Abstract
Cylindrical algebraic decomposition (CAD) is a key tool for problems in real algebraic geometry and beyond. When using CAD there is often a choice over the variable ordering to use, with some problems infeasible in one ordering but simple in another. Here we discuss a recent experiment comparing three heuristics for making this choice on thousands of examples.
- Published
- 2015
- Full Text
- View/download PDF
40. Cost-Effectiveness Analysis Of Continuous Remote Monitoring Of Heart Failure Patients With Cardiac Electronic Implantable Device.
- Author
-
Malbaski, N, Balazs, T, Dozsa, C, and Zima, E
- Subjects
- *
HEART failure patients , *MEDICAL care costs , *COST effectiveness , *PATIENT monitoring , *ARTIFICIAL implants - Published
- 2015
- Full Text
- View/download PDF
41. Topological data analysis to identify cardiac resynchronization therapy patients exhibiting benefit from an implantable cardioverter-defibrillator.
- Author
-
Veres B, Schwertner WR, Tokodi M, Szijártó Á, Kovács A, Merkel ED, Behon A, Kuthi L, Masszi R, Gellér L, Zima E, Molnár L, Osztheimer I, Becker D, Kosztin A, and Merkely B
- Subjects
- Humans, Female, Male, Aged, Middle Aged, Retrospective Studies, Survival Rate trends, Treatment Outcome, Patient Selection, Cardiac Resynchronization Therapy Devices, Data Analysis, Follow-Up Studies, Cardiac Resynchronization Therapy methods, Defibrillators, Implantable, Heart Failure therapy, Heart Failure mortality, Heart Failure diagnosis, Heart Failure physiopathology
- Abstract
Background: Current guidelines recommend considering multiple factors while deciding between cardiac resynchronization therapy with a defibrillator (CRT-D) or a pacemaker (CRT-P). Nevertheless, it is still challenging to pinpoint those candidates who will benefit from choosing a CRT-D device in terms of survival., Objective: We aimed to use topological data analysis (TDA) to identify phenogroups of CRT patients in whom CRT-D is associated with better survival than CRT-P., Methods: We included 2603 patients who underwent CRT-D (54%) or CRT-P (46%) implantation at Semmelweis University between 2000 and 2018. The primary endpoint was all-cause mortality. We applied TDA to create a patient similarity network using 25 clinical features. Then, we identified multiple phenogroups in the generated network and compared the groups' clinical characteristics and survival., Results: Five- and 10-year mortality were 43 (40-46)% and 71 (67-74)% in patients with CRT-D and 48 (45-50)% and 71 (68-74)% in those with CRT-P, respectively. TDA created a circular network in which we could delineate five phenogroups showing distinct patterns of clinical characteristics and outcomes. Three phenogroups (1, 2, and 3) included almost exclusively patients with non-ischemic etiology, whereas the other two phenogroups (4 and 5) predominantly comprised ischemic patients. Interestingly, only in phenogroups 2 and 5 were CRT-D associated with better survival than CRT-P (adjusted hazard ratio 0.61 [0.47-0.80], p < 0.001 and adjusted hazard ratio 0.84 [0.71-0.99], p = 0.033, respectively)., Conclusions: By simultaneously evaluating various clinical features, TDA may identify patients with either ischemic or non-ischemic etiology who will most likely benefit from the implantation of a CRT-D instead of a CRT-P., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
42. The impact of the SARS-CoV-2 pandemic on in-hospital cardiac arrest: A systematic review and meta-analysis.
- Author
-
Fekete-Győr A, Seckington A, Kiss B, Nagy B, Pál-Jakab Á, Kiss DZ, Fehérvári P, and Zima E
- Abstract
Background: There is an emerging concern regarding the indirect effect the Covid-19 pandemic has had on the care provided to patients. New resuscitation guidance including the donning of Personal Protective Equipment before commencing resuscitation efforts, the avoidance of bag-mask ventilation, limiting the number of responders and stopping resuscitation efforts earlier could have led to worse outcomes following in-hospital cardiac arrest (IHCA) when compared to the non-pandemic period. The primary objective was to understand the impact of the pandemic on patient outcomes following IHCA by comparing the pandemic and non-pandemic periods., Methods: Our systematic search was conducted on the 13th of September 2022 in three databases: Medline, Embase and Central. Randomised or non-randomised clinical trials and observational studies were included. The search was repeated on 31st December 2023 and there were no new studies appropriate for inclusion which had been published in the interim. The patient population consisted of adult patients who suffered IHCA due to any cause. The primary outcome was survival to hospital discharge (SHD). The secondary outcomes were return of spontaneous circulation (ROSC) and length of resuscitation., Results: We identified 1873 studies, 9 were included in our qualitative analysis. SHD was reported in 8 studies with no difference between the two periods (OR 0.69; 95% CI 0.47-1.03) along with resuscitation (MD: 0.74; 95% CI: -0.67 to 2.14; p = 0.153. ROSC was included in all studies and showed significant difference between the two periods (OR 0.75; 95% 0.60-0.95)., Conclusion: Although SHD was similar between the two periods, ROSC was significantly lower during the pandemic with longer resuscitation times highlighting a substantial impact of the pandemic on patient outcomes., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
43. Factors predicting mortality in the cardiac ICU during the early phase of targeted temperature management in the treatment of post-cardiac arrest syndrome - The RAPID score.
- Author
-
Nagy B, Pál-Jakab Á, Orbán G, Kiss B, Fekete-Győr A, Koós G, Merkely B, Hizoh I, Kovács E, and Zima E
- Abstract
Introduction: Survival rates after out-of-hospital cardiac arrest (OHCA) remain low, and early prognostication is challenging. While numerous intensive care unit scoring systems exist, their utility in the early hours following hospital admission, specifically in the targeted temperature management (TTM) population, is questionable. Our aim was to create a score system that may accurately estimate outcome within the first 12 h after admission in patients receiving TTM., Methods: We analyzed data from 103 OHCA patients who subsequently underwent TTM between 2016 and 2022. Patient demographic data, prehospital characteristics, clinical and laboratory parameters were already available in the first 12 h after admission were collected. Following a bootstrap-based predictor selection, we constructed a nonlinear logistic regression model. Internal validation was performed using bootstrap resampling. Discrimination was described using the c-statistic, whereas calibration was characterized by the intercept and slope., Results: According to the Akaike Information Criterion (AIC) heart rate (AIC = 9.24, p = 0.0013), age (AIC = 4.39, p = 0.0115), pH (AIC = 3.68, p = 0.0171), initial rhythm (AIC = 4.76, p = 0.0093) and right ventricular end-diastolic diameter (AIC = 2.49, p = 0.0342) were associated with 30-day mortality and were used to build our predictive model and nomogram. The area under the receiver-operating characteristics curve for the model was 0.84. The model achieved a C-statistic of 0.7974, with internally validated acceptable calibration (intercept: -0.0190, slope: 0.7772) and low error rates (mean absolute error: 0.040)., Conclusion: The model we have developed may be suitable for early risk assessment of patients receiving TTM as part of primary post-resuscitation care. The calculator needed for scoring can be accessed at the following link: https://www.rapidscore.eu/., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
44. Non-invasive myocardial work as an independent predictor of postprocedural NT-proBNP in elderly patients undergoing transcatheter aortic valve replacement.
- Author
-
Ladányi Z, Bálint T, Fábián A, Ujvári A, Turschl TK, Nagy D, Straub É, Fejér C, Zima E, Apor A, Nagy AI, Szigethi T, Papp R, Molnár L, Kovács A, Ruppert M, Lakatos BK, and Merkely B
- Abstract
Aortic stenosis has become the most prevalent valvular disease with increasing life expectancy and the ageing of the population, representing a significant clinical burden for health care providers. Its treatment has been revolutionized by transcatheter aortic valve replacement (TAVR) as a safe and minimally invasive option for elderly patients. Left ventricular (LV) functional measurement is of particular importance before TAVR, however, increased afterload significantly influences the conventional echocardiographic parameters. Non-invasive myocardial work examines myocardial deformation in the context of instantaneous LV pressure, thus, it might be a more reliable measure of LV function. Accordingly, we aimed to study non-invasive myocardial work and its relationship with functional outcome following TAVR.We enrolled 90 TAVR candidates (80 [75-84] years; 44% female). Using echocardiography, we quantified ejection fraction (EF), global longitudinal strain (GLS), global myocardial work index (GWI) and global constructive work (GCW) before and 12 months after the procedure. Serum NT-proBNP levels were also measured. EF did not change (52.6 ± 13.1 vs. 54.2 ± 10.5%; p = 0.199), while GLS increased (-13.5 ± 4.6 vs. -15.2 ± 3.8%; p < 0.001). GWI decreased (1913 ± 799 vs. 1654 ± 613 mmHg%; p < 0.001) and so did GCW (2365 ± 851 vs. 2177 ± 652 mmHg%; p = 0.018). History of atrial fibrillation (AF) (β = 0.349) and preprocedural GCW (β = -0.238) were independent predictors of postprocedural NT-proBNP (p < 0.001).GLS, GWI and GCW changed after TAVR while there was no alteration in EF. The preprocedural GCW and history of AF were independent predictors of postprocedural NT-proBNP. Accordingly, myocardial work indices may help patient selection and the prediction of the functional outcome in this population., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
45. A Comparative Investigation of the Pulmonary Vasodilating Effects of Inhaled NO Gas Therapy and Inhalation of a New Drug Formulation Containing a NO Donor Metabolite (SIN-1A).
- Author
-
Oláh A, Barta BA, Ruppert M, Sayour AA, Nagy D, Bálint T, Nagy GV, Puskás I, Szente L, Szőcs L, Sohajda T, Zima E, Merkely B, and Radovits T
- Subjects
- Animals, Administration, Inhalation, Swine, Nitric Oxide Donors administration & dosage, Nitric Oxide Donors pharmacology, Vasodilation drug effects, Pulmonary Artery drug effects, Disease Models, Animal, Hemodynamics drug effects, Lung metabolism, Lung drug effects, Vasodilator Agents administration & dosage, Vasodilator Agents pharmacology, Vasodilator Agents therapeutic use, Male, Molsidomine pharmacology, Molsidomine analogs & derivatives, Nitric Oxide metabolism, Hypertension, Pulmonary drug therapy
- Abstract
Numerous research projects focused on the management of acute pulmonary hypertension as Coronavirus Disease 2019 (COVID-19) might lead to hypoxia-induced pulmonary vasoconstriction related to acute respiratory distress syndrome. For that reason, inhalative therapeutic options have been the subject of several clinical trials. In this experimental study, we aimed to examine the hemodynamic impact of the inhalation of the SIN-1A formulation (N-nitroso-N-morpholino-amino-acetonitrile, the unstable active metabolite of molsidomine, stabilized by a cyclodextrin derivative) in a porcine model of acute pulmonary hypertension. Landrace pigs were divided into the following experimental groups: iNO (inhaled nitric oxide, n = 3), SIN-1A-5 (5 mg, n = 3), and SIN-1A-10 (10 mg, n = 3). Parallel insertion of a PiCCO system and a pulmonary artery catheter (Swan-Ganz) was performed for continuous hemodynamic monitoring. The impact of iNO (15 min) and SIN-1A inhalation (30 min) was investigated under physiologic conditions and U46619-induced acute pulmonary hypertension. Mean pulmonary arterial pressure (PAP) was reduced transiently by both substances. SIN-1A-10 had a comparable impact compared to iNO after U46619-induced pulmonary hypertension. PAP and PVR decreased significantly (changes in PAP: -30.1% iNO, -22.1% SIN-1A-5, -31.2% SIN-1A-10). While iNO therapy did not alter the mean arterial pressure (MAP) and systemic vascular resistance (SVR), SIN-1A administration resulted in decreased MAP and SVR values. Consequently, the PVR/SVR ratio was markedly reduced in the iNO group, while SIN-1A did not alter this parameter. The pulmonary vasodilatory impact of inhaled SIN-1A was shown to be dose-dependent. A larger dose of SIN-1A (10 mg) resulted in decreased PAP and PVR in a similar manner to the gold standard iNO therapy. Inhalation of the nebulized solution of the new SIN-1A formulation (stabilized by a cyclodextrin derivative) might be a valuable, effective option where iNO therapy is not available due to dosing difficulties or availability.
- Published
- 2024
- Full Text
- View/download PDF
46. Obesity paradox in patients with reduced ejection fraction eligible for device implantation - an observational study.
- Author
-
Merkel ED, Behon A, Masszi R, Schwertner WR, Kuthi L, Veres B, Osztheimer I, Papp R, Molnár L, Zima E, Gellér L, Kosztin A, and Merkely B
- Abstract
Aims: Patients with obesity have an overall higher cardiovascular risk, at the same time obesity could be associated with a better outcome in a certain subgroup of patients, a phenomenon known as the obesity paradox. Data are scarce in candidates for cardiac resynchronization therapy (CRT). We aimed to investigate the association between body mass index (BMI) and all-cause mortality in patients eligible for CRT., Methods: Altogether 1,585 patients underwent cardiac resynchronization therapy between 2000-2020 and were categorized based on their BMI, 459 (29%) patients with normal weight (BMI < 25 kg/m2), 641 (40%) patients with overweight (BMI 25- < 30 kg/m2) and 485 (31%) with obesity (BMI ≥ 30 kg/m2). The primary endpoint was all-cause mortality, heart transplantation, and left ventricular assist device implantation. We assessed periprocedural complications and 6-month echocardiographic response., Results: Normal-weight patients were older compared to patients with overweight or obesity (70 years vs. 69 years vs. 68 years; P ‹0.001), respectively. Sex distribution, ischaemic aetiology, and CRT-D implantation rates were similar in the three patient groups. Diabetes mellitus (BMI < 25 kg/m
2 26% vs. BMI 25- < 30 kg/m2 37% vs. BMI ≥ 30 kg/m2 48%; P ‹0.001) and hypertension (BMI < 25 kg/m2 71% vs. BMI 25- < 30 kg/m2 74% vs. BMI ≥ 30 kg/m2 82%; P ‹0.001) were more frequent in patients with overweight and obesity. During the mean follow-up time of 5.1 years, 973 (61%) reached the primary endpoint, 66% in the BMI < 25 kg/m2 group, 61% in the BMI 25- < 30 kg/m2 group and 58% in the BMI ≥ 30 kg/m2 group (log-rank P‹0.05). Patients with obesity showed mortality benefit over normal-weight patients (HR 0.78; 95%CI 0.66-0.92; P = 0.003). The obesity paradox was present in patients free from diabetes, atrial fibrillation, and ischemic events. Periprocedural complication rates did not differ in the three groups (BMI < 25 kg/m2 25% vs. BMI 25- < 30 kg/m2 28% vs. BMI ≥ 30 kg/m2 26%; P = 0.48). Left ventricular ejection fraction improved significantly in all patient groups (BMI < 25 kg/m2 median ∆ $$ \Delta $$ -LVEF 7% vs. BMI 25- < 30 kg/m2 median ∆ $$ \Delta $$ -LVEF 7.5% vs. BMI ≥ 30 kg/m2 median ∆ $$ \Delta $$ -LVEF 6%; P < 0.0001) with a similar proportion of developing reverse remodeling (BMI < 25 kg/m2 58% vs. BMI 25- < 30 kg/m2 61% vs. BMI ≥ 30 kg/m2 57%; P = 0.48); P = 0.75)., Conclusions: The obesity paradox was present in our HF cohort at long-term, patients underwent CRT implantation with obesity and free of comorbidities showed mortality benefit compared to normal weight patients. Patients with obesity showed similar echocardiographic response and safety outcomes compared to normal weight patients., (© 2024 The Author(s). ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.)- Published
- 2024
- Full Text
- View/download PDF
47. Key influences of VDD (DX) ICD selection: Results from a prospective, national survey.
- Author
-
Vamos M, Nemeth M, Kesoi B, Papp R, Polgar B, Ruppert M, Mikler C, Liptak A, Selley T, Balazs T, Szili-Torok T, Zima E, and Zoltan Duray G
- Subjects
- Humans, Prospective Studies, Surveys and Questionnaires, Male, Female, Hungary, Atrial Fibrillation, Aged, Middle Aged, Defibrillators, Implantable
- Abstract
Background: To preserve the benefit of atrial sensing without the implantation of an additional lead, a single-lead ICD system with a floating atrial dipole (DX ICD) has been developed. The purpose of this nationwide survey was to provide an overview of the current key influences of device selection focusing on DX ICD and to test the applicability of a previously published decision-making flowchart of ICD-type selection., Methods: An online questionnaire was sent to all implanting centers in Hungary. Eleven centers reported data from 361 DX ICD and 10 CRT-DX systems implantations between February 2021 and May 2023., Results: The most important influencing clinical factors indicated by the participating doctors were elevated risk of atrial fibrillation (AF)/stroke (56%), risk of sinus/supraventricular tachycardias (SVT) (42%), and a potential need for CRT upgrade in the future (36%). The DX ICD was considered in the majority of cases instead of the VVI system (87%), and only in a small proportion instead of a DDD ICD (13%). 60% of the patients with DX ICDs were also included into remote monitoring-based follow-up. In 83% of the cases, good (>2 mV) or excellent (>5) atrial signal amplitude was recorded within 6 weeks after the implantation., Conclusion: In the current national survey, the most important influencing factors indicated by the implanters for selecting a DX ICD were the elevated risk of stroke or sinus/SVT and a potential need for CRT upgrade in the future. These findings support the use of a previously published decision-making flowchart., (© 2024 The Author(s). Pacing and Clinical Electrophysiology published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
48. Non-invasive assessment of left ventricular contractility by myocardial work index in veno-arterial membrane oxygenation patients: rationale and design of the MIX-ECMO multicentre observational study.
- Author
-
Lakatos BK, Ladányi Z, Fábián A, Ehrenberger R, Turschl T, Bagyura Z, Evrard B, Vandroux D, Goudelin M, Lindner S, Britsch S, Dürschmied D, Zima E, Csikós GR, Túróczi Z, Soltész Á, Németh E, Kovács A, Édes FI, and Merkely B
- Abstract
Introduction and Aims: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is an increasingly utilized therapeutic choice in patients with cardiogenic shock, however, high complication rate often counteracts with its beneficial cardiopulmonary effects. The assessment of left ventricular (LV) function in key in the management of this population, however, the most commonly used measures of LV performance are substantially load-dependent. Non-invasive myocardial work is a novel LV functional measure which may overcome this limitation and estimate LV function independent of the significantly altered loading conditions of VA-ECMO therapy. The Usefulness of Myocardial Work IndeX in ExtraCorporeal Membrane Oxygenation Patients (MIX-ECMO) study aims to examine the prognostic role of non-invasive myocardial work in VA-ECMO-supported patients., Methods: The MIX-ECMO is a multicentric, prospective, observational study. We aim to enroll 110 patients 48-72 h after the initiation of VA-ECMO support. The patients will undergo a detailed echocardiographic examination and a central echocardiography core laboratory will quantify conventional LV functional measures and non-invasive myocardial work parameters. The primary endpoint will be failure to wean at 30 days as a composite of cardiovascular mortality, need for long-term mechanical circulatory support or heart transplantation at 30 days, and besides that other secondary objectives will also be investigated. Detailed clinical data will also be collected to compare LV functional measures to parameters with established prognostic role and also to the Survival After Veno-arterial-ECMO (SAVE) score., Conclusions: The MIX-ECMO study will be the first to determine if non-invasive myocardial work has added prognostic value in patients receiving VA-ECMO support., Competing Interests: BKL, AF and AK report personal fees from Argus Cognitive Inc., outside the submitted report. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (© 2024 Lakatos, Ladányi, Fábián, Ehrenberger, Turschl, Bagyura, Evrard, Vandroux, Goudelin, Lindner, Britsch, Dürschmied, Zima, Csikós, Túróczi, Soltész, Németh, Kovács, Édes and Merkely.)
- Published
- 2024
- Full Text
- View/download PDF
49. The prevalence of frailty and its effect on the outcome in cardiac resynchronization therapy patients.
- Author
-
Kuthi LK, Schwertner WR, Veres B, Merkel ED, Masszi R, Behon A, Kovács A, Osztheimer I, Zima E, Molnár L, Gellér L, Kosztin A, and Merkely B
- Subjects
- Humans, Prevalence, Stroke Volume, Frailty epidemiology, Cardiac Resynchronization Therapy, Heart Failure epidemiology, Heart Failure therapy
- Abstract
Frailty is a complex clinical syndrome associated with aging and comorbidities, which correlates with unfavorable outcomes. However, in heart failure patients, frailty is very common, data is scarce about those, who are eligible for Cardiac Resynchronization Therapy (CRT) implantation. We investigated the incidence of frailty and the association of Frailty Index (FI) with the outcome. Thirty baseline clinical parameters were used by the Rockwood cumulative deficit method to determine patients' FI in our single-center cohort. Based on previous studies, patients with FI ≤ 0.210 were considered as non-frail, those with FI 0.10-0.210 were classified in Frail-1, with FI > 0.10 in Frail-2 groups, respectively. Echocardiographic response after 12 months and all-cause mortality were investigated by frailty groups. Among 1004 included patients, 75 (7%) were considered Non-frail, 271 (27%) grouped in Frail-1, and 658 (66%) in Frail-2 with a median FI of 0.36 (0.28-0.43). Patients in Frail-2 group were older, with more comorbidities compared with non-frail patients or those in Group Frail-1. During the median follow-up time of 4.8 years, 29 (39%) patients died in the Non-frail, 140 (52%) in Frail-1, and 471 (72%) in the Frail-2 groups (log-rank p < 0.001). Group Frail-2 showed an unfavorable outcome compared to the non-frail (HR 2.49, 95%CI 1.92-3.22; p < 0.001) and the Frail-1 group (1.83, 95%CI 1.55-2.16; p < 0.001). In our HFrEF patients eligible for CRT implantation, patients were exceedingly vulnerable with a high prevalence of frailty. The calculated frailty index was associated with outcome and proved to be prevalent in individual risk stratification., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
50. The investigation of the efficiency of basic life support education among high school students: Protocol, design and implementation of an interventional, prospective longitudinal, individually randomised, parallel 1:1 grouped trial.
- Author
-
Maár C, Zima E, Nagy B, Pál-Jakab Á, Szvath P, Kiss B, Fritúz G, Gál J, Merkely B, and Kovács E
- Abstract
Background: Basic life support (BLS) skills are crucial not only for healthcare workers but for all lay people as well. Timely recognition of out-of-hospital cardiac arrest (OHCA) and the initiation of BLS by bystanders before the arrival of healthcare personnel may improve survival. There are several methods of spreading BLS skills and improve BLS skill retention among lay people. One of these methods can be the education of adolescent school children. The introduction of mandatory BLS education in schools was very effective in some European countries to increase the rate of bystander BLS., Methods/design: The current study aims to investigate the efficacy of a BLS training and BLS curriculum among high school children in Hungary. Moreover, the investigators would like to optimise factors influencing skill retention in this first responder group and aim to compare two types of teaching methods: feedback given by the instructor or software-based feedback on the efficacy of chest compressions during the course. This study will be an interventional, assessor blinded, individually randomised parallel group trial recruiting 360 students. BLS skill retention will be assessed at the end of the course, two months after the training and six months after training., Discussion: The current study will increase our knowledge on the methods educating BLS among high school children. The results will help us to create an effective BLS curriculum at schools. Trial registration: ClinicalTrials.gov: NCT06016153. Prospectively registered on 08/2023., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.